Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia

Biological Psychiatry

Volumn 41, Issue 4, 1997, Pages 493-495

  Strous, Rael D ^a,b   Bark, Nigel ^a   Woerner, Margaret ^b   Lachman, Herbert M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

Catechol O methyltransferase; Dopamine; Polymorphism; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0031568907     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00474-X     Document Type: Article

References (35)

1. Aksoy S, Klener J, Weinshilboum RM (1993): Catechol-O-methyltransferase pharmacogenetics: Photoaffinity labelling and Western blot analysis of human liver samples. Pharmacogenetics 3:116-122.
2. Axelrod J, Tomchick R (1958): Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702-705.
3. Bertocci B, Miggiano V, Da Prada M, Dembric Z, Lahm H-W, Malherbe P (1991): Human catechol-O-methyltransferase: Cloning and expression of the membrance associated form. Proc Natl Acad Sci USA 88:1416-1420.
4. Campion D, d'Amato T, Bastard C, et al (1994): Genetic studyof dopamine D1, D2 and D4 receptors in schizophrenia. Psychiatry Res 51:215-230.
5. Carlsson A (1988): The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-186.
6. Chow EWC, Bassett AS, Weksberg R (1994): Velo-cardio-facial syndrome and psychotic disorders: Implications for psychiatric genetics. Am J Med Genet 54:107-112.
7. Coon H, Bylerley W, Holik J, et al (1993): Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am J Hum Genet 52:327-334.
8. Daniels JK, Williams NM, Williams J, et al (1996): No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry 153:268-270.
9. Driscoll DA, Salvin J, Sellinger B, et al (1993): Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndrome: Implications for genetic counselling and prenatal diagnosis. J Med Genet 30:813-817.
10. Dunner DL, Levitt M, Kumbaraci T, Fieve RR (1977): Erythrocyte catechol-O-methyltransferase activity in primary affective disorder. Biol Psychiatry 12:237-244.
11. Ebstein EP, Novick O, Umansky R, et al (1996): Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 12:78-80.
12. Grossman MH, Emanual BS, Budarf ML (1992): Chromosomal mapping of the human catechol-O-methyl transferase gene to 22q11.1-q11.2. Genomics 12:822-825.
13. Karege F, Bovier J-M, Tissot R (1987): The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatr Scand 76:303-308.
14. Lachman HL, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996a): Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
15. Lachman HL, Morrow B, Shprintzen R, et al (1996b): Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial-syndrome. Am J Med Genet 67:468-472.
16. Lindsay EA, Goldberg R, Jurecic V (1995): Velo-cardio-facial syndrome: Frequency and extent of 22q11 deletions. Am J Med Genet 57:514-522.
17. Lotta T, Vidgren J, Tilgmann C, et al (1995): Kinetics of human soluble and membrane bound catechol-O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
18. Lundstrom K, Salminen M, Jalanko A, Savolainen R, Ulmanen I (1991): Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol 10:181-189.
19. Macciardi F, Verga M, Kennedy JL, et al (1995): An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using haplotype relative risk. Hum Hered 44:328-336.
20. Morrow B, Goldberg R, Carlson C, et al (1995): Molecular definition of the 22q11 deletions in velo-cardio facial syndrome. Am J Hum Genet 56:1391-1403.
21. Papolos DF, Faedda G, Veit S, et al (1995): Bipolar spectrum in patients diagnosed with velo-cardio-facial-syndrome: Does hemizygous deletion of chromosome 22q 11 result in bipolar affective disorder. Am J Psychiatry (in press).
22. Persico AM, Wang ZW, Black DW, Andreasen NC, Uhl GR, Crowe RR (1995): Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders. Am J Psychiatry 152:134-136.
23. Philippu C, Hoo JJ, Milech U, Argarwall DP, Schrappe O, Goedde HW (1981): Catechol-O-methyltransferase activity of erythrocytes in patients with endogenous psychosis. Psychiatry Res 4:139-146.
24. Pulver AE, Nestadt G, Goldberg R, et al (1994): Psychotic illness in patients diagnosed with velo-cardio facial syndrome and their relatives. J Nerv Ment Dis 182:476-478.
25. Puzynski S, Bidzinsky A, Mrozek S, Zaluska M (1983): Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness: II. Erythrocyte catechol-O-methyltransferase activity in endogenous depression. Acta Psychiatr Scand 67:96-100.
26. Ravindranathan A, Coon H, DeLisi L, et al (1994): Linkage analysis between schizophrenia and a microsatellite polymorphism for the D5 receptor gene. Psychiatr Genet 4:77-80.
27. Sabate O, Campion D, d'Amato T, et al (1994): Failure to find evidence for linkage or association between the dopamine D3 receptor gene and schizophrenia. Am J Psychiatry 151:107-111.
28. Scambler P, Kelly D, Lindsay E, et al (1992): Velo cardio facial syndrome associated with chromosome 22q11 deletions encompassing the DiGeorge locus. Lancet 339:1138-1139.
29. Scanlon PD, Raymond FA, Weinshilboum RA, (1979): catechol-O-methyltransferase; thermolahile enzyme in erythrocytes of subjects homozygous for the allele for low activity. Science 203:63-65.
30. Shprintzen RJ, Goldberg RB, Lewin ML, et al (1978): A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: Velo-cardio-facial syndrome. Cleft Palate J 15:56-62.
31. Shprintzen RJ, Goldberg RB, Golding-Kushner KJ, Marion RW (1992): Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 42:141-142.
32. Sobell JL, Lind TJ, Sigurdson C, et al (1995): The D5 dopamine receptor gene in schizophrenia: Identification of a nonsense change and multiple missense changes but lack of association with disease. Hum Mol Genet 4:507-514.
33. Spielman RS, Weinshilboum RM (1981): Genetics of red cell COMT activity: Analysis of thermal stability and family data. Am J Med Genet 10:279-290.
34. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I (1994): Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049-1054.
35. Weinshilboum RM, Raymond FA (1977): Inheritance of low erythrocyte catechol-O-methyl transferase activity in man. Am J Hum Genet 29:125-135.